1
|
Sivinski J, Ngo D, Zerio CJ, Ambrose AJ, Watson ER, Kaneko LK, Kostelic MM, Stevens M, Ray AM, Park Y, Wu C, Marty MT, Hoang QQ, Zhang DD, Lander GC, Johnson SM, Chapman E. Allosteric differences dictate GroEL complementation of E. coli. FASEB J 2022; 36:e22198. [PMID: 35199390 PMCID: PMC8887798 DOI: 10.1096/fj.202101708rr] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2021] [Revised: 01/22/2022] [Accepted: 01/25/2022] [Indexed: 11/11/2022]
Abstract
GroES/GroEL is the only bacterial chaperone essential under all conditions, making it a potential antibiotic target. Rationally targeting ESKAPE GroES/GroEL as an antibiotic strategy necessitates studying their structure and function. Herein, we outline the structural similarities between Escherichia coli and ESKAPE GroES/GroEL and identify significant differences in intra- and inter-ring cooperativity, required in the refolding cycle of client polypeptides. Previously, we observed that one-half of ESKAPE GroES/GroEL family members could not support cell viability when each was individually expressed in GroES/GroEL-deficient E. coli cells. Cell viability was found to be dependent on the allosteric compatibility between ESKAPE and E. coli subunits within mixed (E. coli and ESKAPE) tetradecameric GroEL complexes. Interestingly, differences in allostery did not necessarily result in differences in refolding rate for a given homotetradecameric chaperonin. Characterization of ESKAPE GroEL allostery, ATPase, and refolding rates in this study will serve to inform future studies focused on inhibitor design and mechanism of action studies.
Collapse
Affiliation(s)
- Jared Sivinski
- The University of Arizona, College of Pharmacy, Department
of Pharmacology and Toxicology, 1703 E. Mabel St., PO Box 210207, Tucson, AZ
85721
| | - Duc Ngo
- The University of Arizona, College of Pharmacy, Department
of Pharmacology and Toxicology, 1703 E. Mabel St., PO Box 210207, Tucson, AZ
85721
| | - Christopher J. Zerio
- The University of Arizona, College of Pharmacy, Department
of Pharmacology and Toxicology, 1703 E. Mabel St., PO Box 210207, Tucson, AZ
85721
| | - Andrew J. Ambrose
- The University of Arizona, College of Pharmacy, Department
of Pharmacology and Toxicology, 1703 E. Mabel St., PO Box 210207, Tucson, AZ
85721
| | - Edmond R. Watson
- Department of Integrative Structural and Computational
Biology, Scripps Research, La Jolla, CA, USA
| | - Lynn K. Kaneko
- The University of Arizona, College of Pharmacy, Department
of Pharmacology and Toxicology, 1703 E. Mabel St., PO Box 210207, Tucson, AZ
85721
| | - Marius M. Kostelic
- The University of Arizona, Department of Chemistry and
Biochemistry, Tucson, AZ 85721
| | - Mckayla Stevens
- Indiana University School of Medicine, Department of
Biochemistry and Molecular Biology, 635 Barnhill Dr., Indianapolis, IN 46202
| | - Anne-Marie Ray
- Indiana University School of Medicine, Department of
Biochemistry and Molecular Biology, 635 Barnhill Dr., Indianapolis, IN 46202
| | - Yangshin Park
- Indiana University School of Medicine, Department of
Biochemistry and Molecular Biology, 635 Barnhill Dr., Indianapolis, IN 46202,Stark Neurosciences Research Institute, Indiana University
School of Medicine. 320 W. 15th Street, Suite 414, Indianapolis, IN 46202,Department of Neurology, Indiana University School of
Medicine. 635 Barnhill Drive, Indianapolis, IN 46202
| | - Chunxiang Wu
- Department of Molecular Biophysics and Biochemistry, Yale
University, New Haven, CT 06520
| | - Michael T. Marty
- The University of Arizona, Department of Chemistry and
Biochemistry, Tucson, AZ 85721
| | - Quyen Q. Hoang
- Indiana University School of Medicine, Department of
Biochemistry and Molecular Biology, 635 Barnhill Dr., Indianapolis, IN 46202,Stark Neurosciences Research Institute, Indiana University
School of Medicine. 320 W. 15th Street, Suite 414, Indianapolis, IN 46202,Department of Neurology, Indiana University School of
Medicine. 635 Barnhill Drive, Indianapolis, IN 46202
| | - Donna D. Zhang
- The University of Arizona, College of Pharmacy, Department
of Pharmacology and Toxicology, 1703 E. Mabel St., PO Box 210207, Tucson, AZ
85721
| | - Gabriel C. Lander
- Department of Integrative Structural and Computational
Biology, Scripps Research, La Jolla, CA, USA
| | - Steven M. Johnson
- Indiana University School of Medicine, Department of
Biochemistry and Molecular Biology, 635 Barnhill Dr., Indianapolis, IN 46202
| | - Eli Chapman
- The University of Arizona, College of Pharmacy, Department
of Pharmacology and Toxicology, 1703 E. Mabel St., PO Box 210207, Tucson, AZ
85721,Corresponding author
, Phone: 520-626-2741
| |
Collapse
|
2
|
Kumar CMS, Chugh K, Dutta A, Mahamkali V, Bose T, Mande SS, Mande SC, Lund PA. Chaperonin Abundance Enhances Bacterial Fitness. Front Mol Biosci 2021; 8:669996. [PMID: 34381811 PMCID: PMC8350394 DOI: 10.3389/fmolb.2021.669996] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2021] [Accepted: 07/01/2021] [Indexed: 12/12/2022] Open
Abstract
The ability of chaperonins to buffer mutations that affect protein folding pathways suggests that their abundance should be evolutionarily advantageous. Here, we investigate the effect of chaperonin overproduction on cellular fitness in Escherichia coli. We demonstrate that chaperonin abundance confers 1) an ability to tolerate higher temperatures, 2) improved cellular fitness, and 3) enhanced folding of metabolic enzymes, which is expected to lead to enhanced energy harvesting potential.
Collapse
Affiliation(s)
- C M Santosh Kumar
- School of Biosciences and Institute of Microbiology and Infection, University of Birmingham, Birmingham, United Kingdom
| | - Kritika Chugh
- Department of Biotechnology and Bioinformatics, University of Rajasthan, Jaipur, India
| | - Anirban Dutta
- TCS Research, Tata Consultancy Services Ltd., Pune, India
| | - Vishnuvardhan Mahamkali
- Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, Brisbane, QLD, Australia
| | - Tungadri Bose
- TCS Research, Tata Consultancy Services Ltd., Pune, India
| | | | - Shekhar C Mande
- Laboratory of Structural Biology, National Centre for Cell Science (NCCS), Pune, India
| | - Peter A Lund
- School of Biosciences and Institute of Microbiology and Infection, University of Birmingham, Birmingham, United Kingdom
| |
Collapse
|
3
|
Abstract
As the GroES/GroEL chaperonin system is the only bacterial chaperone that is essential under all conditions, we have been interested in the development of GroES/GroEL inhibitors as potential antibiotics. Using Escherichia coli GroES/GroEL as a surrogate, we have discovered several classes of GroES/GroEL inhibitors that show potent antibacterial activity against both Gram-positive and Gram-negative bacteria. However, it remains unknown if E. coli GroES/GroEL is functionally identical to other GroES/GroEL chaperonins and hence if our inhibitors will function against other chaperonins. Herein we report our initial efforts to characterize the GroES/GroEL chaperonins from clinically significant ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species). We used complementation experiments in GroES/GroEL-deficient and -null E. coli strains to report on exogenous ESKAPE chaperone function. In GroES/GroEL-deficient (but not knocked-out) E. coli, we found that only a subset of the ESKAPE GroES/GroEL chaperone systems could complement to produce a viable organism. Surprisingly, GroES/GroEL chaperone systems from two of the ESKAPE pathogens were found to complement in E. coli, but only in the strict absence of either E. coli GroEL (P. aeruginosa) or both E. coli GroES and GroEL (E. faecium). In addition, GroES/GroEL from S. aureus was unable to complement E. coli GroES/GroEL under all conditions. The resulting viable strains, in which E. coli groESL was replaced with ESKAPE groESL, demonstrated similar growth kinetics to wild-type E. coli, but displayed an elongated phenotype (potentially indicating compromised GroEL function) at some temperatures. These results suggest functional differences between GroES/GroEL chaperonins despite high conservation of amino acid identity.IMPORTANCE The GroES/GroEL chaperonin from E. coli has long served as the model system for other chaperonins. This assumption seemed valid because of the high conservation between the chaperonins. It was, therefore, shocking to discover ESKAPE pathogen GroES/GroEL formed mixed-complex chaperonins in the presence of E. coli GroES/GroEL, leading to loss of organism viability in some cases. Complete replacement of E. coli groESL with ESKAPE groESL restored organism viability, but produced an elongated phenotype, suggesting differences in chaperonin function, including client specificity and/or refolding cycle rates. These data offer important mechanistic insight into these remarkable machines, and the new strains developed allow for the synthesis of homogeneous chaperonins for biochemical studies and to further our efforts to develop chaperonin-targeted antibiotics.
Collapse
|
4
|
Vinod V, Pushkaran AC, Kumar A, Mohan CG, Biswas R. Interaction mechanism of Mycobacterium tuberculosis GroEL2 protein with macrophage Lectin-like, oxidized low-density lipoprotein receptor-1: An integrated computational and experimental study. Biochim Biophys Acta Gen Subj 2020; 1865:129758. [PMID: 33031906 DOI: 10.1016/j.bbagen.2020.129758] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2020] [Revised: 09/30/2020] [Accepted: 10/01/2020] [Indexed: 11/18/2022]
Abstract
BACKGROUND Bacterial surface proteins act as potential adhesins or invasins. The GroEL is a signal peptide-free surface expressed protein that aids adhesion in Escherichia coli by binding to LOX-1 receptor of the host cells. Mycobacterium tuberculosis (Mtb) expresses GroEL2 protein, having high level sequence identity with E. coli GroEL. This study investigates the interaction mechanism of GroEL2 protein of Mtb with LOX-1 of macrophages using integrated computational and experimental approach. METHODS Mtb GroEL2 protein was purified as histidine tagged protein using Ni-NTA chromatography. Confocal and scanning electron microscopies were used to study the uptake of GroEL2 coated fluorescent latex beads through the LOX-1 receptor in RAW264.7 macrophage cell line. Docking studies were performed to understand the interaction between the GroEL2 and LOX-1 proteins. Polyinosinic acid (PIA) was used as a LOX-1 inhibitor in both in silico and in vitro experiments. RESULTS GroEL2 protein coating enhances uptake of latex beads into macrophages through LOX-1 receptor. LOX-1 inhibitor PIA decreased the uptake of GroEL2 coated latex beads. GroEL2 interacts with the key ligand binding regions of the LOX-1 receptor, such as the basic spine and the saddle hydrophobic patch. PIA molecule destabilized the LOX-1-GroEL2 docked complex. CONCLUSION Surface associated GroEL2 protein of Mtb is a potential ligand for macrophage LOX-1 receptor. Interaction between GroEL2 and LOX-1 receptor may be utilized by Mtb to gain its intracellular access. GENERAL SIGNIFICANCE Surface associated GroEL2 of Mtb may bind to the macrophage LOX-1 receptor, enabling the internalization of the bacteria and progression of the infection.
Collapse
Affiliation(s)
- Vivek Vinod
- Center for Nanosciences and Molecular Medicine, Amrita Institute of Medical Sciences and Research Center (AIMS), Amrita Vishwa Vidyapeetham, Kochi 682041, Kerala, India
| | - Anju Choorakottayil Pushkaran
- Center for Nanosciences and Molecular Medicine, Amrita Institute of Medical Sciences and Research Center (AIMS), Amrita Vishwa Vidyapeetham, Kochi 682041, Kerala, India
| | - Anil Kumar
- Department of Microbiology, Amrita Institute of Medical Sciences and Research Center, Amrita Vishwa Vidyapeetham, Kochi 682041, Kerala, India
| | - Chethampadi Gopi Mohan
- Center for Nanosciences and Molecular Medicine, Amrita Institute of Medical Sciences and Research Center (AIMS), Amrita Vishwa Vidyapeetham, Kochi 682041, Kerala, India..
| | - Raja Biswas
- Center for Nanosciences and Molecular Medicine, Amrita Institute of Medical Sciences and Research Center (AIMS), Amrita Vishwa Vidyapeetham, Kochi 682041, Kerala, India..
| |
Collapse
|
7
|
Mycobacterium tuberculosis GroEL2 Modulates Dendritic Cell Responses. Infect Immun 2018; 86:IAI.00387-17. [PMID: 29133346 DOI: 10.1128/iai.00387-17] [Citation(s) in RCA: 20] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/02/2017] [Accepted: 11/06/2017] [Indexed: 01/03/2023] Open
Abstract
Mycobacterium tuberculosis successfully subverts the host immune response to promote disease progression. In addition to its known intracellular niche in macrophages, M. tuberculosis interferes with the functions of dendritic cells (DCs), which are the primary antigen-presenting cells of the immune system. We previously showed that M. tuberculosis dampens proinflammatory responses and impairs DC functions through the cell envelope-associated serine protease Hip1. Here we present data showing that M. tuberculosis GroEL2, a substrate of Hip1, modulates DC functions. The full-length GroEL2 protein elicited robust proinflammatory responses from DCs and promoted DC maturation and antigen presentation to T cells. In contrast, the cleaved form of GroEL2, which predominates in M. tuberculosis, was poorly immunostimulatory and was unable to promote DC maturation and antigen presentation. Moreover, DCs exposed to full-length, but not cleaved, GroEL2 induced strong antigen-specific gamma interferon (IFN-γ), interleukin-2 (IL-2), and IL-17A cytokine responses from CD4+ T cells. Moreover, the expression of cleaved GroEL2 in the hip1 mutant restored the robust T cell responses to wild-type levels, suggesting that proteolytic cleavage of GroEL2 allows M. tuberculosis to prevent optimal DC-T cell cross talk during M. tuberculosis infection.
Collapse
|